The MEA2100-Beta-Screen-System is an in vitro
recording system optimized for diabetes research with beta cells in intact islets of Langerhans. Non-invasive in vitro
MEA technology enables acute long-term recording of up to 40 islets simultaneously. Build-in suctions allows fixation and optimal positioning of the islets on the electrodes. The system consists of a 5-channel headstage with build-in perfusion, featuring a sampling rate of 50 kHz per channel at a 24 bit resolution. The digitized data is transferred from the headstage to a signal collector unit for up to four headstages. The signal collector unit is connected via an eSATA cable to the MCS-IFB interface board.
With a multifold MEA2100-Beta-Screen-System up to two signal collectors can be connected to one interface board, thereby creating a system with 8 headstages for parallel recordings.
Read more about beta cell screening on our website www.beta-screen.com.